Clinical trial
Prevalence of Diabetes Among Hospitalized Patients With Covid-19 in West of Algeria. Identification of Diabetes-related Associated Factors Severe Forms
NCT04412746 is registered in ClinicalTrials.gov with Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Diabetes Among Hospitalized Patients With Covid-19 in West of Algeria. Identification of Diabetes-related Associated Factors Severe Forms
- Lead sponsor
- Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2020
- Completion date
- June 30, 2020
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus infections, diabetes mellitus, patient outcome assessment, prevalence, risk factors, severe acute respiratory syndrome